← Open Payments lookup

ERIN DUHAIME: Open Payments

NPI 1801041009 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$43,741 in 194 payments from 19 companies in 2025. Trend: 2023 $34,787 · 2024 $52,323 · 2025 $43,741

Speaker / faculty: $32,411Food & beverage: $5,151Travel & lodging: $3,629Consulting: $2,550
CompanyPaymentsAmount
ViiV Healthcare Company122$33,857
Ferring Pharmaceuticals Inc.6$4,770
Merck Sharp & Dohme LLC15$3,686
Gilead Sciences, Inc.19$705
ABBVIE INC.4$92
PFIZER INC.4$86
Theratechnologies Inc.3$82
EMD Serono, Inc.3$70
Astellas Pharma US Inc3$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$60

Products named: APRETUDE, DOVATO, REBYOTA, PIFELTRO, CABENUVA, Yeztugo, EGRIFTA, RUKOBIA.

Industry payments across TX — which companies pay providers there.